Skip to main content

Table 1 Demographic and clinical characteristics of the study sample

From: Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls

 

Control (N = 86)

Bipolar I (N = 67)

Bipolar II (N = 43)

ANOVA

P

    

F

χ2

 

Age, years: mean (SD)

38.1 (14.5)

38.3 (13.5)

35.7 (12.0)

0.562

 

0.57

Gender (male / female)

39 / 47

32 / 35

16 / 27

 

1.24

0.54

Educational level,1-5: mean (SD)a

4.1

3.8

3.8

1.08

 

0.34

WAISinformation subtest

13,3 (2,3)

13,2 (2,3)

13,6 (2,2)

0,38

 

0,69

Age of onset: mean (SD)

 

20.6 (8.4)

19.1 (8.5)

0.88

 

0.35

Prior psychotic symptoms: N (%)

 

52 (78)

7 (17)

 

39.6

< 0.001

Suicide attempt: N (%)

 

26 (39)

16 (38)

 

0.06

0.94

Interpersonal violence: N (%)

 

20 (30)

10 (23)

 

0.57

0.45

Anxiety disorder

 

19 (28)

24 (56)

 

7.96

0.005

ADHD

 

7 (11)c

10 (23)

 

3.04

0.081

MADRS: mean (SD)

 

3.9 (3.5)

3.6 (3.6)

0.17

 

0.68

YMRS: mean (SD)

 

1.6 (2.7)

2.2 (2.2)

1.2

 

0.28

Lifetime number of manic episodes: mean (SD)

 

3 (2.9)

-

   

Lifetime number of depressive episodes: mean (SD)

 

13.3 (13.2)

28.5 (31.0)

12.4

 

0.001

CGI: mean (SD)

 

4.9 (0.9)

4.1 (0.7)

23.2

 

< 0.001

Pharmacological treatment, N (%)

      

Lithium

 

49 (73)

21 (49)

 

6.7

0.01

Anticonvulsant

 

15 (22)

8 (19)

 

0.22

0.63

Antidepressant

 

18 (27)

19 (44)

 

3.5

0.061

Antipsychotic

 

22 (33)

6 (14)

 

4.9

0.027

Combination therapyb

 

34 (51)

17 (40)

 

1.32

0.25

  1. a1 = less than 9 years, 2 = 9 years, 3 =12 years, 4 = 13–15 years and 5 = more than 15 years of education.
  2. bCombination of 2 or more psychotropic medications.
  3. cMissing data for 2 patients.